GLP-1 Agonists Show Potential as Anti-Addiction Medication in Medical Field, but More Research Needed on Side Effects and Addiction Connection.

According to Sadhu, insulin resistance can disrupt the ovarian cycle, leading to infertility by impacting hormones like estrogen and testosterone as well as the release of eggs from the ovaries. GLP-1 agonists have shown promise as potential anti-addiction medications, according to Christian Hendershot, an addiction researcher. These drugs may help reduce insulin resistance and improve fertility in patients. However, the effects of these drugs on pregnancy are still unknown, so patients should discuss any plans for becoming pregnant with their doctors and consider contraceptive strategies.

As drugs like Ozempic and Mounjaro have become more prevalent, patients have reported unexpected side effects such as reduced desire to smoke or drink. Further research is needed to understand the connection between these drugs and addiction. Luba Yammine, an addiction researcher, suggests that the part of the brain responsible for food cravings may also play a role in cravings for substances of abuse. In the medical field, GLP-1 drugs have shown promise as potential anti-addiction medications. There are limited medications available for treating addiction, and patients often struggle to access them. Additionally, addiction research receives less funding compared to other diseases.